LARONDE
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Sept 2024)
What this means for you
This application is over — abandoned 23 Sept 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90089002
- Mark type
- Stylized text
- Filed
- 03 Aug 2020
- Published for opposition
- 22 Jun 2021
- Abandoned
- 23 Sept 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in gene therapy; biological and pharmaceutical preparations, both comprised of therapeutic nucleic acids, namely RNA, for the treatment and prevention of genetic diseases and disorders, genomic diseases and disorders, cancer, infectious diseases, and immune system related diseases and disorders
- Class 042 — Scientific and technological services: Testing, inspection, research, and development of pharmaceutical preparations for gene therapy
Owner
- SAIL BIOMEDICINES, INC., CAMBRIDGE, MA, US
- LARONDE, INC, Cambridge, MA, US
- LARONDE, INC, CAMBRIDGE, MA, US
- VL50, Inc., Cambridge, MA, US
Prosecution history
- 23 Sept 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Sept 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 17 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Feb 2024 — SOU EXTENSION 5 GRANTED
- 16 Feb 2024 — SOU EXTENSION 5 FILED
- 16 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 15 Nov 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 28 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2023 — SOU EXTENSION 4 GRANTED
- 26 Jul 2023 — SOU EXTENSION 4 FILED
- 26 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2023 — SOU EXTENSION 3 GRANTED
- 06 Jan 2023 — SOU EXTENSION 3 FILED
- 06 Jan 2023 — SOU TEAS EXTENSION RECEIVED